Patients who died of a melanoma thinner than 1.5ram within 96months (group 1, n = 60) were compared with those having a tumor of the same thickness who had not died in this time period (Group 2, n = 300). Both groups were investigated with respect to differences in patient sex and age and to thickne
Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients
β Scribed by G. Ponti; A. Pollio; A.M. Cesinaro; G. Pellacani; C. Magnoni; S. Seidenari
- Book ID
- 116332825
- Publisher
- Elsevier
- Year
- 2012
- Tongue
- English
- Weight
- 209 KB
- Volume
- 36
- Category
- Article
- ISSN
- 1877-7821
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract S100B protein detected in the serum of patients with cutaneous melanoma has been long reported as a prognostic biomarker. However, no consensus exists on its implementation in the routine clinical setting. This study aimed to comprehensively and quantitatively summarize the evidence on
## Background: The current study was performed to determine whether tumor mitotic rate (tmr) is a useful, independent prognostic factor in patients with localized cutaneous melanoma. ## Methods: From the sydney melanoma unit database, 3661 patients with complete clinical information and details o